Pulmonary arteriovenous malformation is an abnormal connection between blood vessels in the lungs, and it can lower oxygen levels in the blood. Many living with pulmonary arteriovenous malformation have no clear warning signs at first, but early symptoms of pulmonary arteriovenous malformation can include shortness of breath, tiredness, nosebleeds, or bluish lips or fingers. It is often present from birth and may be found in adults, especially in people with hereditary hemorrhagic telangiectasia, although some children are diagnosed earlier. Not everyone will have the same experience. Treatment usually involves a procedure to block the abnormal blood vessel, and timely care can lower the risk of stroke, brain abscess, bleeding, and other serious complications.
How many people live with Pulmonary arteriovenous malformation?
Published estimates for pulmonary arteriovenous malformation vary widely because some studies count only diagnosed cases while others also count very small ones found on chest scans. Using the commonly cited range of about 2 to 38 people per 100,000, roughly 160,000 to 3.1 million people worldwide may be living with it (Shovlin, 2014; Nakayama et al., 2012; UN World Population Prospects, 2024), and about 6,800 to 130,000 people in the United States may be affected (Shovlin, 2014; Nakayama et al., 2012; U.S. Census Bureau, 2024).
Overview
Pulmonary arteriovenous malformationSymptoms
Pulmonary arteriovenous malformation may cause shortness of breath, low oxygen levels, and tiredness, especially with activity. Some people notice bluish lips or fingertips, headaches, or nosebleeds. Small pulmonary arteriovenous malformations may cause no symptoms at first.
Outlook and prognosis
For many living with pulmonary arteriovenous malformation, outlook is often good when it is found early and treated, usually by blocking the abnormal blood vessels. Ongoing follow-up matters because new malformations can appear, especially in people with inherited forms.
Causes and risk factors
Pulmonary arteriovenous malformation is usually due to an inherited blood-vessel disorder called hereditary hemorrhagic telangiectasia. Less often, it is linked to liver disease, chest injury, or heart surgery. Pregnancy can raise complication risk.
Genetic influences
Genetics can be very important in pulmonary arteriovenous malformation, especially because many cases are linked to inherited changes seen in hereditary hemorrhagic telangiectasia. Still, not everyone with pulmonary arteriovenous malformation has a known genetic cause.
Diagnosis
Pulmonary arteriovenous malformation is usually diagnosed with imaging, often a chest CT scan and a contrast echocardiogram. Doctors also look at symptoms, oxygen levels, and family history, and genetic tests may help confirm the diagnosis of pulmonary arteriovenous malformation.
Treatment and drugs
Pulmonary arteriovenous malformation is often treated by sealing the abnormal blood vessel during a catheter procedure called embolization. Some people also need oxygen, treatment of nosebleeds or anemia, and regular follow-up scans.
Symptoms
Pulmonary arteriovenous malformation can be easy to miss because some people have no clear warning signs at first. For many people with pulmonary arteriovenous malformation, the main day-to-day problems are breathlessness, low energy, or headaches linked to lower oxygen levels. Larger or multiple malformations can also raise the risk of coughing up blood or sudden neurologic symptoms because blood can bypass the lungs' normal filtering role. Not everyone has the same features, and some are found only after a scan or an unexpectedly low oxygen reading.
Some people with pulmonary arteriovenous malformation feel completely well, and the finding comes up after a scan or a low oxygen reading. Even without clear symptoms, the abnormal vessel connection can still matter because it lets blood bypass part of the lung.
Breathlessness often shows up during exercise, climbing stairs, or walking quickly. Some may also feel more short of breath when sitting or standing upright because oxygen levels can drop in that position.
When less oxygen reaches the body, everyday tasks can feel more tiring than expected. Many living with pulmonary arteriovenous malformation notice fatigue, lightheadedness, or reduced stamina more than chest pain.
Low oxygen can give the lips, fingertips, or skin a bluish tinge, especially during activity. Over time, the fingertips may become rounded or widened, a visible change called clubbing.
How people usually first notice Pulmonary arteriovenous malformation?
Pulmonary arteriovenous malformation is often first noticed because of unexplained shortness of breath, tiring more easily than expected, or a bluish tint to the lips or fingertips from lower oxygen levels. Many people with this condition also come to medical attention after coughing up blood, having frequent nosebleeds or a family history of hereditary hemorrhagic telangiectasia, or after a stroke or brain abscess seems to happen without a clear reason. In others, the first signs of pulmonary arteriovenous malformation are subtle, and it is found by chance on a chest scan or during testing that shows low blood oxygen.
Types of Pulmonary arteriovenous malformation
Doctors describe a few main types of pulmonary arteriovenous malformation based on how the abnormal blood vessel connection is built and how much of the lung it affects. Symptoms don’t always look the same for everyone. Many living with pulmonary arteriovenous malformation have no symptoms at first, but some may notice shortness of breath, low oxygen levels, fatigue, or headaches, and these problems are often more noticeable in the more extensive types of pulmonary arteriovenous malformation.
Simple
This is the most common type, where one feeding artery connects to one draining vein through a single abnormal channel. Many people have no symptoms, especially if it is small, while others may notice breathlessness with activity or lower oxygen levels. It is often found by chance on imaging or during testing after nosebleeds or hereditary hemorrhagic telangiectasia are recognized.
Complex
In this type, two or more feeding arteries connect to the same abnormal vessel area. Symptoms can be more noticeable because a larger amount of blood may bypass the normal air sacs, which can lead to more shortness of breath, tiredness, or bluish lips or fingertips. The risk of complications such as stroke or brain abscess may also be higher if it is not treated.
Diffuse
This less common form involves many small malformations spread through part of one lung or both lungs. People with diffuse pulmonary arteriovenous malformation are more likely to have ongoing low oxygen levels, breathlessness in daily life, and reduced exercise tolerance. In more severe cases, symptoms can begin earlier and affect day-to-day activities more clearly.
Can I slow down the onset of symptoms?
Usually, no: there is no good evidence that lifestyle changes can meaningfully delay the start of symptoms from pulmonary arteriovenous malformation, because it is an abnormal shortcut between blood vessels in the lung rather than a condition mainly driven by diet, exercise, sleep, or other daily habits. Healthy choices like not smoking and staying active support overall lung and heart health, but they are not known to prevent symptoms; the best-established medical step is early screening, especially for people with the inherited blood vessel condition called hereditary hemorrhagic telangiectasia, and treatment to close the abnormal vessel when doctors recommend it to lower the risk of bleeding, low oxygen, or stroke. This cannot guarantee symptoms will never appear, but finding it early can still make a meaningful difference.
What genetics can tell you about symptoms
Genetics can sometimes help explain why pulmonary arteriovenous malformations happen and why symptoms vary from one person to another. Many people with this condition have an inherited disorder called hereditary hemorrhagic telangiectasia, and the gene change involved can influence whether problems such as shortness of breath, low oxygen levels, nosebleeds, or complications from abnormal blood flow are more likely to appear, although it does not predict symptoms perfectly. In general, genetics may offer clues about risk, timing, and overall pattern, but it usually cannot tell exactly how severe symptoms will be for any one person.
Causes and risk factors
The main causes of pulmonary arteriovenous malformation are abnormal blood vessel development before birth. Many cases are linked to an inherited blood vessel disorder called hereditary hemorrhagic telangiectasia. That disorder is often due to gene changes in ENG, ACVRL1, or SMAD4, and these changes can be inherited or happen for the first time in a family. Risk factors for pulmonary arteriovenous malformation also include severe liver disease, chest injury, and some heart or lung procedures. Having a gene change doesn’t mean you’ll definitely develop the condition, and lifestyle habits do not usually cause it, though smoking can make breathing problems worse.
What are the most common causes or risk factors?
The most common cause of a pulmonary arteriovenous malformation is an inherited blood vessel condition called hereditary hemorrhagic telangiectasia, or HHT, so having HHT or a close family member with it is the main risk factor. Many of these abnormal blood vessel connections are present from birth, even if they are not found until later in life. Much less often, they can develop with severe liver disease, after chest injury or surgery, or with some heart conditions.
Environmental and biological risk factors
Pulmonary arteriovenous malformation most often arises from blood vessel changes that start before birth, but some cases develop later because of other medical conditions or injury. When people look into the causes of pulmonary arteriovenous malformation, it helps to know that doctors often group risks into internal (biological) and external (environmental).
Many pulmonary arteriovenous malformations begin when lung blood vessels form in an unusual way before birth. This is the main biological setting in which pulmonary arteriovenous malformation develops.
Severe liver disease, especially cirrhosis and hepatopulmonary syndrome, can raise the chance of abnormal artery-to-vein connections forming in the lungs. In this setting, pulmonary arteriovenous malformation is an acquired rather than birth-related problem.
Certain complex heart conditions present from birth can increase risk, especially after operations that reroute blood flow to the lungs, such as Glenn or Fontan procedures. These blood flow changes seem to make abnormal lung vessel connections more likely over time.
A penetrating chest injury can sometimes lead to an acquired pulmonary arteriovenous malformation. In these cases, healing after the injury may leave an unusual direct link between an artery and a vein.
Genetic risk factors
Most inherited pulmonary arteriovenous malformation is linked to changes in genes that guide how blood vessels grow and separate from one another. The strongest genetic connection is hereditary hemorrhagic telangiectasia, or HHT, which often runs in families. Some risk factors are inherited through our genes. Knowing the genetic causes of pulmonary arteriovenous malformation can help families decide whether genetic counseling or testing may be useful.
Hereditary HHT: Most pulmonary arteriovenous malformations are linked to HHT, an inherited condition that affects how blood vessels develop. People with HHT have a higher chance of forming abnormal blood vessel connections in the lungs and other parts of the body.
ENG changes: Changes in the ENG gene are one of the best known genetic causes of pulmonary arteriovenous malformation. Among people with HHT, this gene is especially strongly linked with lung AVMs.
ACVRL1 changes: Changes in ACVRL1 can also cause HHT and increase the chance of pulmonary arteriovenous malformation. Lung AVMs may be less common with ACVRL1 than with ENG, but they can still occur.
SMAD4 changes: Changes in SMAD4 can cause an overlap condition involving HHT and a tendency to develop many polyps in the digestive tract. People with this gene change can also develop pulmonary arteriovenous malformation.
Family history: Having a parent, sibling, or child with HHT or pulmonary arteriovenous malformation raises your own genetic risk. A family pattern of frequent nosebleeds or abnormal blood vessels can be an important clue even before testing.
New mutations: Sometimes a gene change happens for the first time in one person, so pulmonary arteriovenous malformation can appear without a known family history. Once present, that change can be passed on to future children.
Autosomal dominant: Most HHT-related gene changes follow an autosomal dominant pattern, which means each child of an affected parent has a 1 in 2, or 50%, chance of inheriting the change. Severity can vary widely, even within the same family.
Lifestyle risk factors
Pulmonary arteriovenous malformation is usually a structural blood vessel problem rather than something caused by lifestyle. Still, how lifestyle affects pulmonary arteriovenous malformation can matter because certain habits can worsen low oxygen levels, trigger symptoms, or raise the chance of complications such as stroke or brain abscess. The main lifestyle risk factors for pulmonary arteriovenous malformation are those that increase clotting risk, reduce oxygen delivery, or allow bacteria or air bubbles to bypass the lung’s normal filter.
Smoking or vaping can further reduce oxygen delivery and make breathlessness, fatigue, and exercise intolerance worse in people with pulmonary arteriovenous malformation. It may also add strain to the heart and lungs, which can make symptoms more noticeable.
Long periods of sitting and very low physical activity can increase the risk of blood clots forming in the legs. Because pulmonary arteriovenous malformation allows blood to bypass the lung’s filtering system, a clot can more easily travel onward and cause a stroke or other embolic complication.
Poor fluid intake can thicken the blood and may make clot formation more likely, especially during illness, heat exposure, or long travel. In someone with pulmonary arteriovenous malformation, that can increase the risk of paradoxical embolism through the abnormal vessel connection.
Scuba diving is especially risky because gas bubbles that would normally be filtered out by the lungs can pass through the malformation into the arterial circulation. This can lead to serious neurologic decompression illness, so diving is generally avoided unless a specialist says it is safe after treatment.
Risk prevention
For pulmonary arteriovenous malformation, true prevention is often not possible because many cases are present from birth or linked to inherited conditions such as hereditary hemorrhagic telangiectasia. In daily life, prevention usually means lowering the chance of complications like low oxygen levels, stroke, brain abscess, or bleeding, and finding treatable malformations early. Some may find this becomes relevant after unexplained shortness of breath, frequent nosebleeds, or a scan done for another reason. Different people need different prevention strategies—there’s no single formula.
If pulmonary arteriovenous malformation runs in your family or you have signs of hereditary hemorrhagic telangiectasia, early testing can help find lung vessel changes before they cause harm. This can lower the risk of serious problems such as stroke or brain infection.
Many living with pulmonary arteriovenous malformation can reduce future complications by having treatable abnormal vessels closed, often with a catheter-based procedure. Treating larger or symptomatic malformations is one of the main ways to prevent low oxygen problems and clot-related complications.
Pulmonary arteriovenous malformation can let bacteria bypass the lungs' normal filtering function and reach the brain more easily. Good dental care and, for some people, antibiotics before certain dental or medical procedures may help prevent a brain abscess.
With pulmonary arteriovenous malformation, even small air bubbles in an IV line can travel into the bloodstream and cause harm. Care teams should use careful IV techniques and remove air from syringes and tubing whenever possible.
Can you prevent Pulmonary arteriovenous malformation?
Pulmonary arteriovenous malformations usually cannot be prevented, because many are present from birth or are linked to an inherited condition called hereditary hemorrhagic telangiectasia, or HHT. If HHT runs in your family, family screening and genetic counseling can help find problems early, but they do not stop these abnormal blood vessel connections from forming.
Transmission
Pulmonary arteriovenous malformation is not contagious, so it cannot be passed from one person to another through coughing, kissing, sex, food, or everyday contact. For many living with pulmonary arteriovenous malformation, the more relevant question is how pulmonary arteriovenous malformation is inherited.
Many cases are linked to hereditary hemorrhagic telangiectasia, an inherited condition that can run in families; if a parent has it, each child has a 1 in 2, or 50%, chance of inheriting the gene change. Some pulmonary arteriovenous malformations happen without a family history, including from a new genetic change, and others are not clearly inherited.
When to test your genes
Consider genetic testing when a pulmonary arteriovenous malformation is found, especially if you or relatives have frequent nosebleeds, visible small blood vessel spots, or a history of hereditary hemorrhagic telangiectasia. Testing can uncover an inherited cause and guide screening for the lungs, brain, liver, and family members.
Diagnosis
People with pulmonary arteriovenous malformation may notice shortness of breath, tiring more easily on stairs, or low oxygen levels that do not have an obvious cause. The diagnosis of pulmonary arteriovenous malformation often starts when these day-to-day changes, or coughing up blood or unexplained stroke-like symptoms, lead to testing. Doctors usually begin with a health history, an exam, and simple oxygen checks, then confirm the finding with imaging. Because some cases are linked to hereditary hemorrhagic telangiectasia, family history can also be an important clue.
A clinician asks about breathlessness, nosebleeds, migraines, coughing up blood, and any past stroke or brain abscess. They also look for signs such as low oxygen levels, bluish lips or fingertips, or small widened blood vessels on the skin that can point toward an underlying inherited condition.
Pulse oximetry measures how much oxygen is in the blood and can show lower-than-expected levels at rest or with activity. Blood gas testing may be used in some cases to measure oxygen more precisely and help judge how much the malformation is affecting breathing.
A contrast echocardiogram, often called a bubble study, is a common screening test for pulmonary arteriovenous malformation. Tiny bubbles are injected into a vein, and if they appear in the left side of the heart after a short delay, this suggests an abnormal connection in the lungs.
A chest CT scan with contrast is usually the main test used to confirm the diagnosis and show the size and location of the abnormal blood vessel connection. It also helps doctors decide whether treatment is needed and plan the safest approach.
How is Pulmonary arteriovenous malformation diagnosed?
Pulmonary arteriovenous malformation is usually found with imaging tests that show an abnormal direct connection between blood vessels in the lungs. Doctors often start with a simple oxygen check and an ultrasound of the heart done with tiny bubbles in a vein to look for blood bypassing the lungs, then confirm it with a chest CT scan, often with dye, to see the size and exact location. In some cases, a catheter test that maps the lung blood vessels is used, especially if treatment is being planned, and genetic testing may be offered if there are signs of an inherited condition such as hereditary hemorrhagic telangiectasia.
Stages of Pulmonary arteriovenous malformation
Pulmonary arteriovenous malformation does not have defined progression stages. That is because it is usually described by whether abnormal blood vessel connections are present, how large they are, and whether they are causing problems, rather than by a steady step-by-step decline over time. Doctors usually start with a conversation about symptoms such as shortness of breath, low oxygen levels, nosebleeds, migraines, or coughing up blood, although some people have no symptoms and the early symptoms of pulmonary arteriovenous malformation can be easy to miss. Diagnosis and follow-up are usually based on imaging tests such as a chest CT scan and heart ultrasound with bubbles, along with oxygen checks and monitoring for complications over time.
Outlook and prognosis
The outlook for people with pulmonary arteriovenous malformation is often good when the condition is recognized and treated, especially with embolization, which can reduce low oxygen levels and lower the risk of serious complications. Prognosis depends on the size and number of malformations, whether they recur, and whether the person has hereditary hemorrhagic telangiectasia, which increases the chance of developing new lesions over time. Untreated pulmonary arteriovenous malformations can lead to stroke, brain abscess, severe bleeding, and progressive shortness of breath, so long-term follow-up is important even after successful treatment. Many patients do well for years with monitoring and repeat treatment when needed, although some have persistent or recurrent symptoms. Mortality is generally low with modern diagnosis and treatment, but the risk can rise significantly in people with major bleeding, severe hypoxemia, or neurologic complications. Pregnancy can increase the danger of rupture or bleeding, so affected women usually need specialist care before and during pregnancy.
Long-term effects
Pulmonary arteriovenous malformation can have very different long-term effects depending on its size, number, and whether it is linked to a condition such as hereditary hemorrhagic telangiectasia. Some people have few day-to-day problems, while others develop ongoing low oxygen levels or serious complications from blood bypassing the lungs. Long-term effects vary widely, but careful follow-up matters because risks can change over time even after treatment.
Blood may bypass the normal lung filter, which can leave oxygen levels lower than usual for years. Many people with pulmonary arteriovenous malformation notice shortness of breath, tiring easily, or trouble keeping up with walking, stairs, or exercise.
These abnormal blood vessel connections can let small clots pass through the lungs and reach the brain. Over time, this raises the risk of transient ischemic attack or stroke, sometimes even in people whose early symptoms of pulmonary arteriovenous malformation were mild.
Because the lungs normally help filter germs from the bloodstream, pulmonary arteriovenous malformation can increase the chance of a brain abscess. This is uncommon, but it is one of the most important long-term complications doctors watch for.
Some people may cough up blood or have bleeding into the lung, especially if the malformation is large or fragile. Bleeding can range from mild to severe and may need urgent medical care if it happens.
How is it to live with Pulmonary arteriovenous malformation?
Living with a pulmonary arteriovenous malformation can feel unpredictable because some people have almost no day-to-day symptoms, while others live with shortness of breath, tiring easily, headaches, or low oxygen levels that make exercise and even stairs harder than expected. For many, daily life also includes extra caution around things that raise the risk of complications, along with scans, specialist visits, and sometimes procedures to close the abnormal blood vessel connections, especially if the condition is linked to hereditary hemorrhagic telangiectasia, an inherited blood vessel disorder. The effects often reach beyond the person living with it: family members may worry during episodes of breathlessness or bleeding, help with medical appointments, and sometimes need genetic evaluation themselves, but with good follow-up and treatment, many people are able to protect their health and keep a full routine.
Treatment and drugs
Pulmonary arteriovenous malformation is treated by closing the abnormal blood vessel connection that lets blood bypass the lungs, because this can improve oxygen levels and lower the risk of problems such as stroke, brain abscess, or bleeding. The main treatment is usually a minimally invasive procedure called embolization, where a specialist threads a thin tube through a blood vessel and places tiny coils or plugs to block the malformation. Small pulmonary arteriovenous malformations that are not causing trouble may sometimes be monitored, but many living with pulmonary arteriovenous malformation are advised to treat larger or symptomatic ones even if the early symptoms of pulmonary arteriovenous malformation have been mild. Treatment plans often combine several approaches. People with pulmonary arteriovenous malformation may also need follow-up scans over time, treatment of low iron if present, and extra precautions before certain procedures, especially when the condition is linked to an inherited disorder such as hereditary hemorrhagic telangiectasia.
Can you cure Pulmonary arteriovenous malformation?
A pulmonary arteriovenous malformation, meaning an abnormal connection between blood vessels in the lung, can often be treated very effectively, but there is not always a permanent cure for the tendency to form them. Doctors usually treat it by blocking the abnormal vessel from the inside or, less often, with surgery, which can improve oxygen levels and lower the risk of bleeding or stroke. Many living with this condition still need regular follow-up because a treated vessel can reopen or new ones can form, especially when it is linked to an inherited condition.
Non-drug treatment
Living with pulmonary arteriovenous malformation can mean getting short of breath with everyday activity, feeling unusually tired, or having low oxygen levels because blood is bypassing the lungs’ normal filter. Treatment is often centered on procedures and supportive care rather than daily medicines, with the goal of improving oxygen levels and lowering the risk of serious problems such as stroke or brain infection. Not every approach works the same way, and the best plan depends on the size, number, and location of the malformations, as well as whether pulmonary arteriovenous malformation is linked to an inherited condition such as hereditary hemorrhagic telangiectasia.
This is the main non-drug treatment for most pulmonary arteriovenous malformations and is done by threading a thin tube into a blood vessel to seal the abnormal connection. Many people go home the same day or after a short stay, and it often improves oxygen levels while reducing the risk of complications.
Surgery may be used when embolization is not possible or has not worked well enough, especially for a single malformation in an accessible part of the lung. It is used less often now, but it can still be an effective option in selected cases.
Supplemental oxygen can help if blood oxygen levels are low and you feel breathless during rest, sleep, or activity. It does not remove the malformation, but it can make day-to-day life easier while other treatment is planned or if symptoms continue.
Regular scans and oxygen checks help your care team see whether treated vessels stay closed and whether new ones appear over time. This is especially important because some people have few symptoms at first, so early symptoms of pulmonary arteriovenous malformation can be easy to miss.
Your genes may have an impact on how drugs work for you
For people with pulmonary arteriovenous malformation, genes usually do not play a big day-to-day role in choosing medicines, because treatment is most often based on closing the abnormal blood vessel connection with a procedure rather than relying on long-term medication. The genetic side matters more for understanding why the condition happened, especially when it runs in families, than for predicting how well a medicine will work or what side effects it may cause. In other words, medicine choices for this condition are usually guided by the size and location of the vessel problem, oxygen levels, and bleeding risk, not by drug-response genetic testing.
Pharmacological treatments
For pulmonary arteriovenous malformation, medicines usually do not remove or seal the abnormal blood vessel connection itself; procedures such as embolization are the main treatment. Medication can feel like a big step, but in this condition drugs are mostly used to prevent complications or to treat related problems such as low iron or infection risk. Because needs vary from person to person, the treatment plan often depends on oxygen levels, symptoms, and whether any pulmonary arteriovenous malformation remains after a procedure.
There is no medicine that can close a pulmonary arteriovenous malformation by itself. When people search for the best medication for pulmonary arteriovenous malformation, the key point is that drugs are supportive, while embolization is usually the main treatment.
Antibiotics may be recommended before dental work or certain invasive procedures in people with untreated or residual pulmonary arteriovenous malformation. This is done to lower the chance of bacteria entering the bloodstream and causing a serious brain infection such as an abscess.
Iron tablets or intravenous iron may be used when pulmonary arteriovenous malformation occurs with chronic blood loss, especially in people who also have hereditary hemorrhagic telangiectasia and frequent nosebleeds. Replacing iron can help improve fatigue, shortness of breath, and low iron anemia.
Oxygen is not a drug, but it may be prescribed when pulmonary arteriovenous malformation leads to low blood oxygen levels. Some medicines work quickly, while others take time, and oxygen can help symptoms right away even though it does not fix the malformation itself.
Genetic influences
Pulmonary arteriovenous malformation is often linked to inherited factors, especially when it happens as part of hereditary hemorrhagic telangiectasia, or HHT. HHT is passed down in families in an autosomal dominant pattern, so a parent with the gene change has a 1 in 2 chance of passing it on to each child. For many, this comes to light after years of frequent nosebleeds in the family or when more than one relative is found to have unusual blood vessel changes in the lungs. Family history is one of the strongest clues to a genetic influence. Not every pulmonary arteriovenous malformation is inherited, but if there is a family history of pulmonary arteriovenous malformation or other signs of HHT, genetic counseling and sometimes genetic testing can help clarify risk for close relatives.
Is Pulmonary arteriovenous malformation genetic?
Genetics can be very important in pulmonary arteriovenous malformation, especially because many cases are linked to inherited changes seen in hereditary hemorrhagic telangiectasia. Still, not everyone with pulmonary arteriovenous malformation has a known genetic cause.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are common and are a normal part of human biology across the general population. Most do not directly affect health and simply reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some instances, though, one well-studied variant in a particular gene is enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
Genes can matter in pulmonary arteriovenous malformation because many people with this condition have hereditary hemorrhagic telangiectasia (HHT), an inherited disorder that makes abnormal blood vessel connections more likely. If testing confirms HHT, doctors usually screen more carefully for other vessel problems in the lungs, brain, and liver, and they may suggest testing for close relatives as well. This genetic information does not usually change the main treatment for pulmonary arteriovenous malformation, which is most often a procedure to block the abnormal blood vessel rather than a medicine. There is also no standard drug chosen by a gene result to directly treat or close a pulmonary arteriovenous malformation. Genetics is only one factor, and doctors also use symptoms, scan results, oxygen levels, and the size and number of malformations when deciding on treatment and follow-up. For many families, understanding the genetic causes of pulmonary arteriovenous malformation helps guide early screening and safer long-term care.
Interactions with other conditions
People with pulmonary arteriovenous malformation can feel more short of breath or tired if they also have heart or lung disease, because their blood already picks up less oxygen than usual as it moves through the lungs. Day-to-day, it can feel like one health issue amplifies the other, such as when mild anemia, asthma, or chronic lung disease makes walking upstairs or carrying groceries noticeably harder. Pulmonary arteriovenous malformation is also closely linked with hereditary hemorrhagic telangiectasia, an inherited condition that can cause frequent nosebleeds and abnormal blood vessels in several parts of the body. This matters because people living with both may have a higher chance of complications such as low oxygen levels, migraines, stroke, or brain abscess, especially if the lung malformation allows small clots or bacteria to bypass the lungs’ usual filtering role. Pregnancy can place extra strain on the heart and blood vessels, so pulmonary arteriovenous malformation may need closer monitoring before and during pregnancy. If you are wondering about early symptoms of pulmonary arteriovenous malformation, it is also worth asking how other conditions you have might affect breathing, oxygen levels, and treatment choices.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Pulmonary arteriovenous malformation?
Other causes of shortness of breath and low oxygen, such as asthma, pneumonia, long-term lung disease like emphysema or chronic bronchitis, or a blood clot in the lung, can seem similar at first. Some heart problems, including heart failure or a heart defect present from birth, may also cause tiredness, bluish lips or fingers, or low oxygen levels, so doctors often check for these too.
History
People living with pulmonary arteriovenous malformation may have gone years in the past without a clear explanation for symptoms like getting short of breath more easily, tiring quickly, or having low oxygen levels for reasons that did not fit common lung diseases. Early doctors could describe the pattern, but they had limited tools to see what was happening inside the lungs, so these abnormal blood vessel connections were often recognized only after serious complications or during surgery or autopsy.
As medical science evolved, pulmonary arteriovenous malformation became better understood as a problem in which blood can pass from arteries to veins in the lungs without moving through the usual tiny vessels that help pick up oxygen and filter small particles. That helped explain why some people developed bluish lips or fingertips, and why others had problems that seemed unrelated at first, such as coughing up blood or certain kinds of stroke or brain infection.
In the 20th century, chest X-rays and later more detailed imaging made it much easier to spot these changes in living patients. Doctors also began to notice that pulmonary arteriovenous malformation sometimes appeared alongside other inherited conditions, which pushed research forward even before the biology was fully worked out. Not every early description was complete, yet together they built the foundation of today’s knowledge.
Treatment changed the story in an important way. In the past, surgery was sometimes the only option for larger or troublesome malformations. Over time, less invasive catheter-based procedures were developed, allowing doctors to block many of these abnormal vessel connections from inside the blood vessels rather than through open surgery. For many, this meant shorter recovery and a safer way to reduce the risk of bleeding, low oxygen, and complications affecting the brain.
Today, the history of pulmonary arteriovenous malformation is also a story about earlier recognition. Modern imaging and better awareness mean that early symptoms of pulmonary arteriovenous malformation are more likely to be investigated before a crisis happens. Even so, diagnosis can still be delayed because symptoms may be mild or mistaken for more common problems, especially when the condition is small or found by chance during a scan done for another reason.